(Q39826592)

15 September 2017

title

Endogenous μ-opioid peptides modulate immune response towards malignant melanoma (English)

1 reference

15 September 2017

0 references

3

Dirk Schadendorf

1 reference

15 September 2017

Sandra Boehncke

1

1 reference

15 September 2017

Katja Hardt

2

1 reference

15 September 2017

Reinhard Henschler

4

1 reference

15 September 2017

Wolf-Henning Boehncke

5

1 reference

15 September 2017

Beatrice Duthey

6

1 reference

15 September 2017

publication date

18 October 2010

1 reference

15 September 2017

published in

Experimental Dermatology

1 reference

15 September 2017

volume

20

1 reference

15 September 2017

issue

1

1 reference

15 September 2017

page(s)

24-28

1 reference

Psychotropic Agents in Opiate Addiction: A Brief Review

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01158.X

Regional mu opioid receptor regulation of sensory and affective dimensions of pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01158.X

Deficit in attachment behavior in mice lacking the mu-opioid receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01158.X

Cloning of a delta opioid receptor by functional expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01158.X

Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01158.X

kappa-Opioid receptor in humans: cDNA and genomic cloning, chromosomal assignment, functional expression, pharmacology, and expression pattern in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01158.X

mu opiate receptor: cDNA cloning and expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01158.X

Neuroimmune mechanisms of opioid-mediated conditioned immunomodulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01158.X

Immunomodulatory activity of mu- and kappa-selective opioid agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01158.X

Opioid peptides mediate the suppressive effect of stress on natural killer cell cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01158.X

Alteration of early T cell development by opioid and superantigen stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01158.X

Opioid and nociceptin receptors regulate cytokine and cytokine receptor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01158.X

Brain peptides (first of two parts).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01158.X

Beta-endorphin in the immune system: a role at last?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01158.X

Hypothalamic beta-endorphin concentrations are decreased in animal models of autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01158.X

beta-Endorphin-containing memory-cells and mu-opioid receptors undergo transport to peripheral inflamed tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01158.X

Anti-inflammatory properties of the mu opioid receptor support its use in the treatment of colon inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01158.X

Increased splenocyte proliferative response and cytokine production in beta-endorphin-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01158.X

Neuroendocrine activity of the melanocyte

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01158.X

Opioid peptides in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01158.X

Immune suppression in the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01158.X

alpha-Melanocyte stimulating hormone, inflammation and human melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01158.X

Opiates transdeactivate chemokine receptors: delta and mu opiate receptor-mediated heterologous desensitization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01158.X

Expression of opioid peptides in tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01158.X

Novel opioid antagonists for opioid-induced bowel dysfunction and postoperative ileus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01158.X

Morphine analgesia suppresses tumor growth and metastasis in a mouse model of cancer pain produced by orthotopic tumor inoculation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0625.2010.01158.X

10.1111/J.1600-0625.2010.01158.X

21 January 2018

Identifiers

DOI

1 reference

15 September 2017

1 reference